NYSE:MRK Merck & Co., Inc. Q3 2026 Earnings Date & Estimates $145.25 -1.99 (-1.35%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$145.40 +0.15 (+0.10%) As of 10/23/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Merck & Co., Inc. is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 9:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 29, 2026TimeBefore Market OpensConference Call9:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Merck & Co., Inc. in Q3 2026Merck & Co., Inc. is expected to post earnings of $2.09 per share on revenue of $17.31 billion. In the same quarter a year earlier Merck & Co., Inc. reported $2.58 per share on revenue of $17.28 billion. Merck & Co., Inc. last reported on August 4, 2026, posting -$0.13 per share and beating the -$0.26 consensus estimate. Merck & Co., Inc. has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$2.09Expected Revenue$17.31 billionPrior-Year EPS$2.58Prior-Year Revenue$17.28 billionExpected EPS Growth-19.0%Expected Revenue Growth+0.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.13 (Beat by +$0.13)Last Quarter Revenue$16.61 billionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Merck & Co., Inc. Q3 2026 Earnings FAQ When does Merck & Co., Inc. report Q3 2026 earnings? Merck & Co., Inc. (NYSE:MRK) is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Merck & Co., Inc.'s Q3 2026 earnings call? Merck & Co., Inc.'s Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 9:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Merck & Co., Inc.? Analysts expect Merck & Co., Inc. to post earnings of $2.09 per share for Q3 2026. How much revenue is Merck & Co., Inc. expected to report? The consensus revenue estimate for Merck & Co., Inc. is $17.31 billion for Q3 2026. Merck & Co., Inc. Earnings HeadlinesFY2026 Earnings Estimate for MRK Issued By Erste Group BankOctober 25 at 1:13 AM | americanbankingnews.comCan Merck (MRK) Stay Undervalued If Cash Flow Keeps Growing?October 24 at 12:19 PM | finance.yahoo.comCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This past May, flooding hit the same complex again, and in July Cigar Lake went down a second time, disrupting the world's largest high-grade uranium mine. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.October 25 at 1:00 AM | Digest Publishing (Ad)Stock Traders Purchase Large Volume of Call Options on Merck & Co., Inc. (NYSE:MRK)October 24 at 2:13 AM | americanbankingnews.comModerna stock extends losses as investors digest melanoma vaccine trial dataOctober 23 at 9:16 PM | finance.yahoo.comMerck & Co., Inc.October 23 at 4:15 PM | cnn.comSee More Merck & Co., Inc. Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck & Co., Inc.? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck & Co., Inc. and other key companies, straight to your email. Email Address About Merck & Co., Inc.Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that develops, manufactures and markets prescription medicines, vaccines and animal-health products. Its pharmaceutical business focuses on oncology, infectious diseases, cardiology, immunology and other areas of significant medical need. The company serves patients, healthcare providers and institutions in markets worldwide. Merck’s principal products include Keytruda, an immunotherapy used to treat a range of cancers; Gardasil and Gardasil 9, vaccines that help protect against human papillomavirus; and Januvia and Janumet, medicines used to manage type 2 diabetes. Its portfolio also includes products such as Bridion, which reverses certain effects of muscle-relaxing medicines used during surgery. Through Merck Animal Health, the company provides vaccines, pharmaceutical products and technology-enabled solutions for livestock, companion animals and aquaculture. The company traces its roots to the U.S. operations established by the Merck family in 1891 and operates independently from Germany-based Merck KGaA, which uses the name EMD in the United States and Canada. Merck & Co. has research, manufacturing and commercial operations across North America, Europe, Asia-Pacific, Latin America, Africa and other international markets. Robert M. Davis serves as the company’s chairman and chief executive officer.View Merck & Co., Inc. ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestSpotify Soars After Earnings as the Company Touts AI Benefits and Moderating CostsWhy Western Digital's AI Storage Boom Defies the Chip Sell-OffPalantir's Next Big Test Isn't a Partnership—It's the Numbers Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
